Phycomyces is a fungal producer of ␤-carotene and other beneficial metabolites. Several erg mutants of Phycomyces, originally selected to study the effects of membrane alteration on physiological responses, have now been used to gain information about sterol biosynthesis in filamentous fungi. One mutant, H23, and its progeny were found to be blocked at episterol C-5 dehydrogenase and did not produce ergosterol or any other sterol with a conjugated ⌬ 5,7 diene system. This mutant showed abnormal phototropism, which was correlated with the altered sterol composition. Another mutant, H25, seems to be a regulatory mutant. All analyzed mutants synthesized ergosta-7,22,24(28)-trien-3␤-ol, demonstrating for the first time that the sterol C-22 dehydrogenase of Phycomyces is capable of recognizing sterols with a 24(28) unsaturated side chain. New evidence regarding the biogenesis of neoergosterol and phycomysterols, the potential sparking function of cholesterol, as well as the regulation of sterol biosynthesis in this fungus is also reported. Given these results, a pathway for sterol biosynthesis in Phycomyces is proposed.
Introduction
The increasing resurgence of fungi as important human pathogens, has stimulated the search for new compounds with antifungal activity. The main groups of antifungal compounds in clinical use all interact with or inhibit ergosterol, the major sterol in the fungal plasma membrane [1] . An exact understanding of fungal ergosterol biosynthesis and metabolism is therefore crucial for the design of novel, more specific and more effective antifungal drugs. Most of the basic research on the biosynthetic pathway leading to ergosterol has focused on the non-pathogenic yeast Saccharomyces cerevisiae [2] . Thus, in 1973, multiple pathways for the ergosterol biosynthesis in yeast were proposed [3] . Subsequently, several erg mutants of Saccharomyces were isolated, numerous genes were cloned and the main biosynthetic pathway from mevalonate, via lanosterol, zymosterol, fecosterol, and other intermediates, was definitively established in yeast [4] . On the other hand, research into sterol biosynthesis in filamentous fungi, which include human pathogens such as Aspergillus fumigatus, has been limited. It seems certain that in many filamentous fungi the metabolic steps from lanosterol to fecosterol differ from those observed in yeast, proceeding via eburicol (4,4-dimethyl-5␣-ergosta-8,24(28)-dien-3␤-ol) [5] [6] [7] , instead of zymosterol. However, some uncertainty still exists regarding the exact sequence of steps from fecosterol to ergosterol in these fungi. Phycomyces (Mucoraceae) is a filamentous fungus producer of ␤-carotene and other beneficial metabolites, whilst mycotoxins never have been found in this organism [8, 9] . Different mutants of Phycomyces have proven to be very useful tools in the dissection of various metabolic pathways, especially in the case of carotene biosynthesis [10] . However, in spite of their presumable usefulness for research on sterol biosynthesis, erg mutants of Phycomyces have not been previously reported. Recently, an exhaustive analysis of sterols and triterpenoids from Phycomyces was carried out in our laboratory, and thus more than twenty compounds were unambiguously identified in the wild-type strain NRRL 1555 [11] . With the sterol profile of the wild-type fungus well established, we have isolated erg mutants of Phycomyces and submitted them to chemical and physiological analysis. The results are reported in this paper.
Experimental

General
Common experimental procedures were carried out as previously described [11] .
Strains
All mutant strains were derived from Phycomyces blakesleeanus NRRL1555 (Ϫ), the wild-type used in sensory physiology experiments [12] . C242 (carA5 nicA101 (ϩ)) has been previously described [13] . H23 (erg-302 (Ϫ)) and H25 (erg-303 (Ϫ)) were isolated from independent mutagenesis experiments described below. H37 (nicA101 erg-302 (ϩ)) and H38 (carA5 erg-302 (Ϫ)) were isolated from a cross of C242 and H23.
Culture conditions
For production and selection of mutants, minimal medium [14] supplemented with 0.1% yeast extract and 0.1% Bacto-Casitone (Difco) was used as a complete medium (CM). Stock solutions of nystatin (Calbiochem) in polyethylene glycol were stored at Ϫ20°C in the dark for up to one month. The drug was added to the medium immediately before pouring the plates. Media were solidified with 1.5% (plates) or 0.7% (top agar) agar. For experiments on sterol production, mutant strains H23, H25, H37 and H38 were incubated in 50 flasks, each containing 100 ml of minimal medium, as previously described for wild-type Phycomyces [11] . Additionally, the media for mutant H37 contained nicotinic acid (for which it is auxotrophic) to a final concentration of 1 mg/l (sterilized by filtration through a 0.22 m-pore membrane, Millipore). For physiological experiments cultures were grown in shell vials containing a defined, minimal medium, SIII, with 0.2 g asparagine/l as a nitrogen source [15] .
Extraction and sterol analysis
Fungal mycelia were harvested by vacuum filtration, lyophilized and weighed. The dry weights of mycelia obtained for each strain were: H23, 27.70 g; H25, 36.35 g; H37, 9.80 g; and H38, 38.39 g. Sterols were extracted and analyzed by means of semipreparative HPLC, NMR spectroscopy and GC-MS techniques, as previously reported for the wild-type strain [11] . Mass spectra and relative retention times of trimethylsilyl (TMS) ethers of 1-21 matched those already reported [11] . Ergosta-7,22,24(28)-trien-3␤-ol (22) 
Physiological analysis
Physiological analysis was carried out as follows: Phototropic thresholds and geotropism were measured as described by Bergman et al. [17] and Ootaki et al. [18] , and avoidance as described by Cohen et al. [19] . Phototropism of single sporangiophores was observed with a measuring microscope fitted with a goniometer eyepiece using a protocol described by Galland et al. [20] .
Results
Production and selection of mutants
Mutants of NRRL1555 were induced with ultraviolet light. Spores were irradiated with approximately 80 Jm Ϫ2 to give 10 -15% survival, plated on CM, and allowed to produce sporangiophores. Spores from several plates were pooled and tested by plating in CM top agar and then at 15 h, when the young germlings were growing rapidly, overlaying additional CM top agar containing 25 g/ml nystatin. Plates were incubated in the dark for 2-3 days and mycelia that grew up were isolated for retesting. Spores from these colonies were tested on CM containing 1 g/ml nystatin and a sporangium from a healthy colony was picked. This cycle was repeated several times until growth on drug plates equaled or exceeded growth on CM. Because strains were tested in the first generation after mutagenesis to allow for segregation and expression of a recessive phenotype, exact calculation of the mutation frequency is not possible, but it is estimated to be about 1 in 10 5 , which is comparable to other mutation rates in Phycomyces. The original isolates were classified into several groups according to their resistance to the polyene antibiotics nystatin and amphotericin B, their sensitivity to the aminoglycoside neomycin, and differences in sterol composition as estimated by ultraviolet absorbance spectra and thin layer chromatography. H23 and H25 are representative of two such groups.
Sterol analysis
The sterols from mutants H23, H25, H37 and H38 were analyzed using GC-MS, semipreparative HPLC and NMR techniques (see Experimental for more details). The quantities of sterols were estimated by calculating the area under each peak of the GC-MS chromatograms. The results are shown in Table 1 . Sterols and triterpenoids previously found in the wild type strain (1-21) [11] have been also included in Table 1 , in order to facilitate further comparison with mutants. Sterol 22, found in mutants, was not previously detected in the wild type strain. Chemical structures of sterols 1-22 are depicted in Scheme 1 and Chart 1.
Physiological analysis
The mutants H23 and H25 are resistant to nystatin, crossresistant to the polyene amphotericin B, but sensitive to the aminoglycoside neomycin, which also interacts with membranes [21] . Table 2 gives the relative levels of resistance for these mutants compared with the wild-type strain. Phototropism at moderated light intensities, gravitropism and the avoidance reaction appear normal in both strains (data not shown). However, phototropism of H23 is altered at low light levels. Photogeotropic equilibrium (phototropic threshold) curves for the mutant and wild type are given in Fig. 1 . H25 again appears to be normal.
Discussion
This report describes the first erg mutants of Phycomyces. As shown in Table 1 , ergosterol (9) , as well as the sterols 7, 8, 11 and 12 (which also have the ⌬ 5,7 -conjugated diene nucleus) were not detected in mutant H23 and in its progeny, the H37 and H38 strains. This fact indicates that in these mutants the enzyme episterol C-5 dehydrogenase (Scheme 1, step f) is inhibited or absent. Evidence that the pathway is blocked at this point is also provided by the observations that these mutants accumulate episterol (6) (the natural substrate of this enzyme) and ergosta-7,22-dien-3␤-ol (14) (the presumable end product in these mutants). The remaining mutant, H25, seems to be a regulatory mutant: it accumulates ergosterol amounts like the wild type strain, but the levels of metabolites 6 and 14 increase whilst the levels of triterpenoids 1-3 diminish. The polyene antibiotics nystatin and amphotericin B are fungicidal because they interact with ergosterol in fungal membranes leading to increased membrane permeability, leakage of cytoplasmic contents and cell death [1] . Thereby, the polyene antibiotic resistance shown by the H23 mutant can be attributed to the lack of ergosterol. On the other hand, the origin of the antibiotic resistance of the H25 mutant is less clear, because it synthesizes normal levels of ergosterol. In this way, the possibility that the sterols 6 and/or 14, accumulated by this mutant, can act preventing (or repairing) the presumable damage produced by the polyene antibiotics on the membrane structures containing ergosterol, can not be ruled out. It has been proposed that in the route preferred by most fungi (including Phycomyces), the transformation of 6 into 9, going through 7 (see Scheme 1), takes place via the [7] . There are two possible explanations for these phenomena: that the normal route passes solely via 8, or that both possible pathways occur but 23 is not accumulated because it is converted very efficiently into 9 by the action of the sterol C-24 reductase. The fact that 22 was produced at all in mutant strains is the first experimental evidence demonstrating that the sterol C-22 dehydrogenase of Phycomyces is capable of recognizing sterols with the 24(28) unsaturated side chain, supporting the hypothesis that both routes may be taken in wild-type Phycomyces. On the basis of these results and the chemical structures of sterols and triterpenoids previously found in the wild-type strain NRRL1555 [11] , a biosynthetic path- way for sterols in Phycomyces is proposed in Scheme 1. The presence of 22 in the mutants, but not of its counterpart 23 in the wild-type, can be explained by a slower rate of conversion of 22314 (relative to the rate of conversion of 2339 in the wild-type) and hence its accumulation. If this is indeed the case, it would appear that the enzyme responsible for this step-the sterol C-24 reductase-does not act as well on substrates which lack the ⌬ 5,7 -conjugated diene nucleus.
It is generally assumed that ergosterol (9) is the end product of sterol biosynthesis in fungi. Nevertheless, chemical structures of neoergosterol (10) and ergosta-5,7,9 (11),22-tetraen-3␤-ol (12) , which were found in the wildtype strain [11] , strongly suggest that these products may be metabolites of 9. The lack of these sterols in mutants, which do not synthesize ergosterol, is in agreement with this hypothesis and, in this way, they are included in Scheme 1 (however the possibility that 12 derives from 11 can not be discarded). It is noteworthy that neoergosterol (10), as well as phycomysterols 15 and 16, show a tetracyclic nucleus with an aromatic B ring closely related to that of 19-norcholesta-5,7,9-trien-3␤-ol (24) (Chart 1) found in patients with the Smith-Lemli-Opitz syndrome (SLOS) [23] , a multiple anomaly disorder which has raised a renewed medical interest in recent years [24] . In these patients a severe defect in late cholesterol biosynthesis leads to the accumulation of high levels of 7-dehydrocholesterol (25) and cholesta-5,8-dien-3␤-ol (26) [25, 26] . It has been reported that 24 detected in SLOS patients might be an artifact formed from 26 under the conditions of GC-MS analysis [26] . However, evidence of the true metabolic origin of neoergosterol (10) in Phycomyces [11] , coupled with the absence of 10, 15 and 16 in mutants lacking sterols with the ⌬ 5,7 diene system, supports the hypothesis that the biosynthesis of sterols with an aromatic B ring takes place via ⌬ 5, 7 diene precursors in fungi.
The detection of cholesterol (18) (a sterol characteristic for mammals) and sitosterol (19) (characteristic for plants) in wild-type and mutant strains H23 and H25, also deserves comment. It is unlikely that substances 18 or 19 detected are exogenous: the media used for growth of mycelia is chemically defined and contains no identifiable sources of these compounds (e.g. animal, vegetable or yeast extracts). If the 18 or 19 detected are indeed produced by the fungus then the gene product involved in the formation of their ⌬ 5 double bond could be different from that responsible for the formation of the ⌬ 5 conjugated double bond of 7 from 6, which is the episterol C-5 dehydrogenase inhibited in our mutants. Another possible explanation is that the biosynthesis of 18 and 19 takes place in a separate cellular compartment, apparently unaffected by the mutation. More intriguingly, after the cross between H23 and C242 strains, sitosterol disappears but cholesterol production is retained (at least at trace levels) in H37 and H38 strains. On the basis of feeding experiments, Parks and co-workers concluded that a sterol with ⌬ 5 -unsaturation is required to accomplish the sparking function needed for growth in yeast [27] . Mutant H23 and its progeny grew well, giving mycelial weights similar or slightly higher than that of the wildtype strain [11] in the cases of H23 and H38 strains (the lower mycelial weight of H37 could be related to its nicotinic acid auxotrophy). Thereby, assuming that the sterol sparking function is necessary for growth in Phycomyces, there are two possibilities: a) that, in contrast to yeast, the sparking function is accomplished by a sterol without any ⌬ 5 -unsaturation; or b) that cholesterol can be responsible for the sparking function in Phycomyces. The fact that mutants here described retain cholesterol biosynthesis, in spite of the fact that their episterol C-5 dehydrogenase is inhibited, lends support to the latter possibility. Nevertheless, additional mutants must be studied in order to confirm this hypothesis.
Increased total sterol content and especially increased end product 14, were seen in mutant H23 (and to a lesser extent in its progeny H37 and H38). It is known that the enzyme HMGCoA reductase is subject to feedback inhibition by ergosterol in yeast [28] . Thereby, the possibility that 9 plays a regulatory role in a feedback system (presumably at the level of HMGCoA reductase) which controls the rate of sterol biosynthesis in Phycomyces, must be considered. Its absence in mutant strains would lead to deregulation of the pathway and sterol overproduction. However, the regulation mechanism of sterol biosynthesis in Phycomyces seems to be more complex. The lack of triterpenoids (1-4) in mutants H23, H37 and H38 can be explained if they are converted into 4-demethyl sterols so quickly that they cannot be detected; indicating the existence of an additional regulatory mechanism (acting on sterol C-24 methyltransferase and other enzymatic systems involved in the a-d steps of Scheme 1), which is inhibited in these mutants. Moreover, the altered sterol profile of the H25 mutant (which presents normal ergosterol levels) strongly suggests that, apart from ergosterol, other elements can be involved in the regulation of sterol biosynthesis in Phycomyces. Finally, the regulation of sterol acylation is also altered in strain H23 and its progeny. Thus, only relatively low amounts of steryl esters were found in these mutants.
At least part of the Phycomyces sensory system is thought to lie within the plasma membrane, hence particular alterations of the membrane may lead to altered behavior. Mutant H23 has the physiological phenotype of a class 1 Mad mutant [17] but with a smaller change in the phototropic threshold than previously found. (A second mutant, isolated after nitrosoguanidine mutagenesis and since lost, had the same phenotype as H23). This change may be associated with the altered sterol content, possibly the absence of sterols with a ⌬ 5,7 -conjugated diene, because H25, which retains ergosterol production, has wild-type physiology. Cholesterol modulates formation of metarhodopsin II [29] and the function of ion channels [30] . These are indirect effects of cholesterol, associated with increased order in fluid regions and interaction with sphingolipids in raft-like microdomains (reviewed in Ref. [31] ). The H23 mutant thus represents a biochemical change in the membrane, which may be associated with abnormal behavior in Phycomyces.
The sterol biosynthesis pathway depicted in Scheme 1 is consistent with the known sterols in other filamentous fungi and should be useful in future drug design. In this way, the presumable involvement of the sterol C-24 methyltransferase (step a, Scheme 1) in a repression mechanism of the fungal sterol biosynthesis is noteworthy, because this enzyme is unique to fungi and, thus, it has been recognized as a particularly attractive drug target [1] . The precise knowledge of this mechanism could facilitate the development of novel and more selective antifungal drugs. The possible hormone-like (sparking) functions of cholesterol in some fungi must be also considered; specially taking into account that, in contrast with mammals, there is little information about the cholesterol biosynthesis in fungi or sterol uptake by pathogenic fungi. Finally, the presumable fungal transformation of ergosterol (9) and others sterols containing the ⌬ 5,7 -diene system into neoergosterol (10) and other ring B aromatic sterols (closely related with those accumulated by SLOS patients), needs to be confirmed. At the moment, several experiments are being performed in our laboratory, in order to gain information about the above items. 
